Substituted benzopyrans as selective estrogen receptor &bgr; agonists
US6630508B1 · kind B1 · utility
10Cited by
0References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 22, 2003 |
| Grant date | Oct 7, 2003 |
| Priority date | — |
| Expiry date | Jan 22, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D311/94
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to substituted benzopyran derivatives, stereoisomers, and pharmaceutical acceptable salts thereof and processes for the preparation of the same. The compounds of the present invention are useful as Estrogen Receptor &bgr; agonists. Such agonists are useful for treating Estrogen Receptor &bgr; mediated diseases such as prostate cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.